BioSpace News Archive

AbbVie (NYSE: ABBV) today announced it will present 23 abstracts at the 31st European Academy of Dermatology and Venereology (EADV) Congress.

CereVasc, Inc. announced completion of the first eShunt ® procedure in the United States.

NewAmsterdam Pharma today announced emerging data adding to the growing body of clinical evidence supporting a shift in the treatment paradigm towards prioritizing a combination approach as first-line therapy for very high-risk atherosclerotic cardiovascular disease (ASCVD) patients.

Tranquis Therapeutics, Inc. today announced it will present preclinical data on the anti-aging effects of TQS-168, a small molecule modulator of PGC-1 a, at ARDD 2022, the 9th Aging Research and Drug Discovery meeting, taking place August 29 to September 2, 2022 at the University of Copenhagen, Denmark.

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), today announced the continuing success of PolyTope® TATX-03 antibody combination therapy to neutralize variants of concern of the COVID-19 causative virus, including the latest Omicron BA.5 subvariant, validated by an independent research organization in an authentic virus assay.

Galecto, Inc. (NASDAQ: GLTO), today announced a recent publication in the Journal of Cancer Research and Clinical Oncology,1 a peer-reviewed scientific journal, supporting the Company’s ongoing clinical programs by reinforcing the foundational galectin-3 biology underlying Galecto’s approach to the inhibition of galectin-3 for the treatment of cancer.

AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is pleased to provide this corporate update on the Company’s Q2 results.

ALR Technologies SG Pte. Ltd, the diabetes management company, announces a distribution agreement with a global leader in animal health is now anticipated to be complete in September.

SQI Diagnostics Inc. today reported its financial and operational results for the third quarter for fiscal year ending September 30, 2022.

GBS Inc. today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2022, shortly after the NASDAQ market close on Wednesday, August 31.